Category: ODD/BTA/FTA Status Region: Asia · China Company: Astrazeneca Pharmaceuticals China Co Ltd

Daiichi Sankyo And Astrazenecas Enhertu Receives Us Fda Breakthrough Therapy Designation To Treat Patients With Her2 Low Metastatic Breast Cancer

Daiichi Sankyo And Astrazenecas Enhertu Receives Us Fda Breakthrough Therapy Designation To Treat Patients With Her2 Low Metastatic Breast Cancer
Daiichi Sankyo And Astrazeneca

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!